Alison Estabrook

3.1k total citations · 1 hit paper
46 papers, 2.1k citations indexed

About

Alison Estabrook is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Alison Estabrook has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 20 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Alison Estabrook's work include Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (15 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Alison Estabrook is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Breast Lesions and Carcinomas (15 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Alison Estabrook collaborates with scholars based in United States, Israel and Switzerland. Alison Estabrook's co-authors include Paul Ian Tartter, Sharon R. Smith, Ira J. Bleiweiss, Aye Moe Thu, Jeffrey J. Kirshner, George W. Sledge, Clifford A. Hudis, Richard E. Fine, Gini F. Fleming and Stephen B. Edge and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Alison Estabrook

46 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2001 616 citations Alison Estabrook et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Estabrook United States	22	1.3k	905	823	574	244	46	2.1k
Roger E. Moe United States	23	1.4k 1.1×	1.0k 1.1×	611 0.7×	1.1k 1.9×	292 1.2×	39	2.4k
Luigi Cataliotti Italy	30	1.9k 1.4×	1.2k 1.3×	747 0.9×	1.5k 2.6×	342 1.4×	101	3.0k
F. Campana France	22	1.2k 0.9×	732 0.8×	350 0.4×	840 1.5×	320 1.3×	68	2.0k
Lorie L. Hughes United States	15	1.5k 1.2×	804 0.9×	493 0.6×	1.1k 1.9×	214 0.9×	22	2.2k
Eugene D. Gierson Switzerland	18	1.8k 1.4×	1.6k 1.7×	715 0.9×	729 1.3×	190 0.8×	27	2.3k
Marcella Del Vecchio Italy	14	2.3k 1.7×	1.3k 1.4×	1.1k 1.3×	1.2k 2.1×	275 1.1×	18	3.1k
Elisa Port United States	27	2.0k 1.5×	1.1k 1.2×	784 1.0×	1.4k 2.4×	291 1.2×	74	3.1k
Stefan Paepke Germany	24	1.6k 1.2×	585 0.6×	544 0.7×	1.4k 2.5×	340 1.4×	144	2.8k
Mirsada Begovič United States	12	2.1k 1.6×	1.1k 1.3×	755 0.9×	1.9k 3.3×	386 1.6×	19	3.2k
Karin Zedeler Denmark	22	2.6k 2.0×	1.5k 1.7×	1.1k 1.3×	1.5k 2.6×	344 1.4×	34	3.5k

Countries citing papers authored by Alison Estabrook

Since Specialization

Citations

This map shows the geographic impact of Alison Estabrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Estabrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Estabrook more than expected).

Fields of papers citing papers by Alison Estabrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Estabrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Estabrook. The network helps show where Alison Estabrook may publish in the future.

Co-authorship network of co-authors of Alison Estabrook

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Estabrook. A scholar is included among the top collaborators of Alison Estabrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Estabrook. Alison Estabrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ilonzo, Nicole, et al.. (2016). Short-term, postoperative breast cancer outcomes in patients with advanced age. The American Journal of Surgery. 212(4). 677–681. 12 indexed citations

Thu, Aye Moe, et al.. (2008). Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. The American Journal of Surgery. 196(4). 500–504. 95 indexed citations

Estabrook, Alison, Sharon R. Smith, Susan K. Boolbol, et al.. (2008). Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?. The American Journal of Surgery. 196(4). 527–529. 107 indexed citations

Tartter, Paul Ian, et al.. (2006). The signficance of surgical margins for patients with atypical ductal hyperplasia. The American Journal of Surgery. 192(4). 499–501. 16 indexed citations

Menes, Tehillah S., Paul Ian Tartter, Ira J. Bleiweiss, et al.. (2005). The Consequence of Multiple Re-Excisions to Obtain Clear Lumpectomy Margins in Breast Cancer Patients. Annals of Surgical Oncology. 12(11). 881–885. 74 indexed citations

El‐Tamer, Mahmoud, Donna Russo, Andrea B. Troxel, et al.. (2004). Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers. Annals of Surgical Oncology. 11(2). 157–164. 47 indexed citations

Tang, Deliang, Andrew Rundle, LaVerne A. Mooney, et al.. (2003). Sulfotransferase 1A1 (SULT1A1) Polymorphism, PAH-DNA Adduct Levels in Breast Tissue and Breast Cancer Risk in a Case-Control Study. Breast Cancer Research and Treatment. 78(2). 217–222. 40 indexed citations

Tartter, Paul Ian, et al.. (2003). The Significance of Atypical Lobular Hyperplasia at Percutaneous Breast Biopsy. The Breast Journal. 9(1). 10–12. 56 indexed citations

Menes, Tehillah S., Paul Ian Tartter, Howard H. Mizrachi, Sharon R. Smith, & Alison Estabrook. (2003). Touch Preparation or Frozen Section for Intraoperative Detection of Sentinel Lymph Node Metastases From Breast Cancer. Annals of Surgical Oncology. 10(10). 1166–1170. 58 indexed citations

10.

Kaplan, Jess L., et al.. (2003). Breast conservation in patients with multiple ipsilateral synchronous cancers. Journal of the American College of Surgeons. 197(5). 726–729. 39 indexed citations

11.

Tang, Deliang, Andrew Rundle, Senqing Chen, et al.. (2002). Polymorphisms in the DNA Repair Enzyme XPD are Associated with Increased Levels of PAH–DNA Adducts in a Case-Control Study of Breast Cancer. Breast Cancer Research and Treatment. 75(2). 159–166. 83 indexed citations

12.

Gajdos, Csaba, et al.. (2002). Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer*. Journal of Surgical Oncology. 80(1). 4–11. 67 indexed citations

13.

Tartter, Paul Ian, Csaba Gajdos, Sharon R. Smith, Alison Estabrook, & Alfred Rademaker. (2002). The prognostic significance of Gail model risk factors for women with breast cancer. The American Journal of Surgery. 184(1). 11–15. 10 indexed citations

14.

Campbell, Anne, et al.. (1998). Short-Term Outcome of Chronic Immunosuppression on the Development of Breast Lesions in Premenopausal Heart and Lung Transplant Patients. Journal of Surgical Research. 78(1). 27–30. 10 indexed citations

15.

Sultan, Mark R., Michael L. Smith, Alison Estabrook, Freya Schnabel, & Davinder Singh. (1997). Immediate Breast Reconstruction in Patients with Locally Advanced Disease. Annals of Plastic Surgery. 38(4). 345–351. 39 indexed citations

16.

Estabrook, Alison, et al.. (1992). Importance of Adequate Staging and of Hormone Receptors in Women Older Than Age 70 With Breast Cancer. Annals of Surgery. 216(1). 22–26. 12 indexed citations

17.

Gutierrez, Maya, et al.. (1992). Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons. Cancer Immunology Immunotherapy. 35(5). 315–324. 8 indexed citations

18.

Yemul, Shrishailam, et al.. (1991). Tumor localization in nude mice bearing human breast carcinoma xenografts using 111In-DTPA conjugates of monoclonal antibodies. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(3). 295–304. 2 indexed citations

19.

Yemul, Shrishailam, Carole L. Berger, M Katz, et al.. (1990). Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells. Cancer Immunology Immunotherapy. 30(6). 317–322. 11 indexed citations

20.

Komaki, Ritsuko, James D. Cox, Sven J. Kister, F. E. Gump, & Alison Estabrook. (1990). Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy.. Radiology. 174(1). 255–257. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact